- Global Pharma News & Resources

Vasculitis - Pipeline Insight, 2019 -

The "Vasculitis - Pipeline Insight, 2019" drug pipelines has been added to's offering.

Vasculitis - Pipeline Insight, 2019 offers a comprehensive insight of the pipeline (under development) therapeutics scenario and growth prospects across Vasculitis development.

The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.

Pipeline Products covered across the following Developmental Stages:

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.

Scope of the Report

  • The report provides a snapshot of the pipeline development for the Vasculitis
  • The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Vasculitis
  • The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Vasculitis
  • The report also covers the dormant and discontinued pipeline projects related to Vasculitis

Topics Covered

1. Report Introduction

2. Vasculitis Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Vasculitis

4. Comparative Analysis

5. Products in Clinical Stage

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

  • Product Description
  • Research and Development
  • Product Development Activities

Companies Featured

  • AnGes MG Inc.
  • ChemoCentryx Inc.
  • Cipla Ltd.
  • Coherus BioSciences Inc.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Hemostemix Ltd.
  • Johnson & Johnson
  • K-Stemcell Co. Ltd.
  • Panacea Biotec Limited
  • Pfizer Inc.
  • Sandoz International GmbH
  • Teijin Pharma Limited

For more information about this drug pipelines report visit

View source version on

Editor Details

Last Updated: 31-Jan-2019